FilingReader Intelligence
Leadman Biochemistry stock jumps 45% on acquisition plans
August 2, 2025 at 05:32 AM UTC•By FilingReader AI
Beijing Leadman Biochemistry's stock price jumped 45.06% over two trading days following announcement of plans to acquire up to 70% of Beijing Xiansheng Xiangrui Biological Products through a cash transaction.
The acquisition constitutes a major asset restructuring currently in preliminary planning stages.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Leadman Biochemistry publishes news
Free account required • Unsubscribe anytime